SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

The Federal Reserves interest-rate hike is driving attention, with traders debating whether it was already reflected in SoFis guidance and share price. Bulls argue higher rates may support the banking arm and that the company anticipated further hikes, while skeptics point to higher funding costs, weaker lending demand and renewed downside pressure.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that sports-event contracts can be treated as gambling rather than federally regulated swaps is driving attention, with traders viewing it as a potential regulatory win for DraftKings against Kalshi and other prediction markets. Debate remains over whether the ruling offsets concerns about competition, margin pressure, and DraftKings own investment in prediction products, contributing to a sharply divided reaction.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of topline Phase 3 APPROACH results for HLP003 in major depressive disorder is driving attention, following ahead-of-schedule enrollment and expectations for a Q4 2026 readout. Traders are broadly bullish on the drugs Phase 2 profile, recent executive and insider buying, and psychedelic-sector momentum, while others cite dilution risk, profit-taking, and uncertainty around the clinical outcome.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Reported insider buying by CEO Ryan Cohen, along with expectations for further share repurchases, is driving attention as GameStop shares climb. Traders are also speculating about a possible Roaring Kitty return and an options-fueled short squeeze, though some view the move as low-volume and potentially temporary.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

The failed or contested Salad and Go site acquisition is a major focus, with traders debating whether Dutch Bros avoided an expensive deal or lost a key expansion opportunity. Attention is also driven by the sharp selloff and valuation compression in a high-PE consumer stock, with bulls citing strong growth, store expansion and busy locations while bears point to weaker discretionary spending, competition, higher rates and possible dilution speculation.

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Schrodinger Inc

Schrdingers formation of Tectra, contributing two early-stage small-molecule programs in exchange for an ownership stake, milestones and royalties, is the main catalyst traders are citing for the sharp advance. The community is broadly bullish on the capital-light structure and AI-driven drug-discovery theme, while some debate whether the move reflects takeover speculation or short-term momentum and warn the stock may be overbought.

PolySwarm

Renewed trading volume and momentum in PolySwarm are attracting speculative interest, with traders focusing on its thin supply, low market capitalization, and potential breakout. The community is split between a bullish view tied to its cybersecurity utility and broader altcoin recovery, and concerns that repeated pumps may be followed by sharp selloffs.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Merck and Modernas positive Phase 3 results for a personalized mRNA cancer vaccine are being viewed by traders as validating Personalis genomic technology and Tempus AIs planned acquisition of the company. The reaction is broadly bullish, with traders highlighting the potential for short- and gamma-squeeze activity, while others caution that the move may be sympathy-driven and has pushed valuation ahead of fundamentals.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

The planned Starship Flight 14 test is the dominant catalyst, with traders focusing on the launch schedule, its potential transition toward commercial Starlink deployment, and the implications of a successful or delayed mission. The community is split between bullish momentum and short-squeeze expectations versus concerns about elevated valuation, upcoming share unlocks, and heavy options volatility.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

Anticipation of BlackBerrys September 24 earnings report, alongside the announced QNX-Sift integration for streaming live sensor data from physical-AI systems, is driving attention. Bulls view the partnership and broader QNX robotics and AI positioning as evidence of growth, while skeptics want stronger revenue guidance and remain wary of management and post-earnings follow-through.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Feed

News

Sentiment

Fundamentals

Info

CLCD CoLucid Pharmaceuticals

Latest CLCD News